NCT03535324View on ClinicalTrials.gov

Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT)

NACompletedINTERVENTIONAL

Enrollment

659

Participants

Timeline

Start Date

October 5, 2018

Primary Completion Date

June 30, 2022

Study Completion Date

May 31, 2023

Conditions

Antibiotic Resistant Infection

Interventions

BEHAVIORAL

PROA for optimization

The development of a ASP based on Reinforcement, Guidance and Support Programs, to prescribing physicians for the optimization of antimicrobial use based on a non-tax counseling program and evidence-based recommendations.

OTHER

Control

There will be no intervention

Trial Locations (3)

11009

Puerta del Mar Hospital, Cadiz

41009

Virgen Macarena Hospital, Seville

50009

Lozano Blesa Hospital, Zaragoza

All Listed Sponsors

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT03535324 - Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT) | Biotech Hunter | Biotech Hunter